Patents (1436 Stem Cell Patents)

Methods of use of FGF homologs

Patent Number: 7,135,459

Date of First Priority Issue: Monday October 16th, 2006
Date Issued: Tuesday November 14th, 2006
Assignee: ZymoGenetics, Inc. (Seattle, WA)
Inventors: Deisher; Theresa A. (Seattle, WA), Conklin; Darrell C. (Seattle, WA)

From Class: Expansion
Comments: No comments

This patent covers the use of zFGF-5 (currently known as FGF-18) for expansion in vitro and in vivo of chondrocytes and neural stem cells. According to the Zymogenetics website, FGF-18 is out-licensed to Serono for use in cartilage repair and stroke. The product is in preclinical phases of testing.

While the specification provides numerous uses for FGF-18, the claims are restricted to one independent claim covering a method of augmenting cartilage deposition through administration of FGF-18 and various homologous thereof. The independent claim describes the use for treating injury of: fibrocartilage, hyaline, or elastic cartilage.

Fibrocartilage is comprised of mixture of fibrous and cartilaginous tissue. The fibrous tissue endows structural strength, whereas the cartilaginous tissue endows elasticity. There are 4 types of fibrocartilage: interarticular, connecting, circumferential, and stratiform. Fibrocartilage is found in symphyseal joints, intervertebral and articular discs.

Hyaline cartilage is found in joints (articular cartilage) and inside bones. When bones are injured, hyaline cartilage is often replaced by fibrocartilage, which can not bear weight as efficiently.

Elastic cartilage is found in areas such as the epiglottis, the pinna of the ear, and the walls of the auditory canal.

The dependent claims cover the use of FGF-18 for treating conditions such as osteoarthritis, rheumatoid arthritis, and traumatic injury.

The examples section of the patent provides several interesting uses for FGF-18, including:

1. Treatment of cardiomyopathy. What appears to be a prophetic example, describes the induction of cardiomyopathy by either chronic catecholamine injection, or ligation of the coronary artery, and treatment of this condition through administration of FGF-18. However, in Example 14, this experiment is actually performed, and reduction of cardiomyopathy is seen.

2. Increasing bone density. Adenovirally delivered FGF-18 appeared to increase bone density in CD-1 mice.

3. In vitro neural stem cell proliferation.

4. Stimulation of bone marrow cell proliferation.

5. Stimulation of osteogenesis.

View this patent on the USPTO website.

Added to StemCellPatents.com on Sunday November 19th, 2006

Social & Bookmarking:Digg 'Methods of use of FGF homologs' Add 'Methods of use of FGF homologs' to del.icio.us Add 'Methods of use of FGF homologs' to Technorati Stumble 'Methods of use of FGF homologs' Add 'Methods of use of FGF homologs' to Furl Add 'Methods of use of FGF homologs' to Reddit Add 'Methods of use of FGF homologs' to Blinklist Add 'Methods of use of FGF homologs' to Ma.gnolia Share 'Methods of use of FGF homologs' on Facebook Add 'Methods of use of FGF homologs' to Google Add 'Methods of use of FGF homologs' to Yahoo Web 

Add Comment

You must be signed-in to add your comments.

Sign-in now or Join the StemCellPatents.com Community for free.



Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2024 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Stouffville Real Estate Agent